Literature DB >> 14718295

Graded full-thickness anterior blepharotomy for upper eyelid retraction.

Victor M Elner1, Adam S Hassan, Bartley R Frueh.   

Abstract

BACKGROUND: A chief morbidity of Graves eye disease is upper eyelid retraction that results in exposure keratopathy and cosmetic deformity.
OBJECTIVE: To assess the efficacy of graded anterior blepharotomy to treat upper eyelid retraction.
METHODS: Fifty eyelids of 32 patients with Graves eye disease-associated upper eyelid retraction, causing symptomatic ocular exposure, were treated with graded, transcutaneous, full-thickness, anterior blepharotomy. Preoperative and postoperative ocular exposure symptoms, upper eyelid position, lagophthalmos, and keratopathy were compared.
RESULTS: At a mean +/- SD of 8.5 +/- 8.1 months' (range, 2-35 months) follow-up, more than 90% of preoperative symptoms resolved or improved. Upper eyelid position (P<.001), lagophthalmos (P<.001), and keratopathy (P<.01) were significantly improved. Mild contour abnormalities (all </=1 mm) occurred in 7 of 50 eyelids. Eyelid crease recession or asymmetry occurred in 4 of 22 patients with postoperative eyelid crease measurements. Complications of ptosis, wound dehiscence, and a full-thickness hole each occurred once. The mean +/- SD time taken to perform the procedure was 31.5 +/- 8.9 minutes per eyelid.
CONCLUSIONS: Graded anterior blepharotomy for upper eyelid retraction is a safe and highly effective surgery for upper eyelid retraction associated with symptomatic Graves eye disease. This technique achieves excellent functional and cosmetic outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 14718295     DOI: 10.1001/archopht.122.1.55

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Thyroid-associated orbitopathy.

Authors:  Adel H Alsuhaibani; Jeffrey A Nerad
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

2.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

3.  Incidence and clinical characteristics of pediatric eyelid retraction.

Authors:  Jessica A Olayanju; Gregory J Griepentrog; Brian G Mohney
Journal:  J AAPOS       Date:  2019-06-20       Impact factor: 1.220

4.  Full thickness eyelid transsection (blepharotomy) for upper eyelid lengthening in lid retraction associated with Graves' disease.

Authors:  C Hintschich; C Haritoglou
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

5.  Müllerotomy with anterior graded Müller muscle disinsertion for Graves upper eyelid retraction: validation of surgical outcomes using Bézier curves.

Authors:  Marco Sales-Sanz; Fernando J Huelin; Cristina Ye-Zhu; Antonio A V Cruz; Francisco J Muñoz-Negrete; Gema Rebolleda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-08       Impact factor: 3.535

6.  The Efficacy of Orbital Septal Flap in the Treatment of Moderate and Severe Upper Eyelid Retraction.

Authors:  Que Anh Vu; Thu Hien Nguyen; Van Anh Bui; Khanh Van Pham; Joohyun Kim; Sehyun Baek
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021-08-25       Impact factor: 2.011

7.  The graded levator hinge procedure for the correction of upper eyelid retraction (an American Ophthalmological Society thesis).

Authors:  Daniel P Schaefer
Journal:  Trans Am Ophthalmol Soc       Date:  2007

8.  A Promising Modified Procedure for Upper Eyelid Retraction-Associated Graves' Ophthalmopathy: Transconjunctival Lateral Levator Aponeurectomy.

Authors:  Fatima Khatavi; Kobra Nasrollahi; Alireza Zandi; Maryam Panahi; Mahshid Mortazavi; Mohsen Pourazizi; Behzad Ranjbar-Omidi
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

9.  Minimally invasive surgery for thyroid eye disease.

Authors:  Milind Neilkant Naik; Akshay Gopinathan Nair; Adit Gupta; Saurabh Kamal
Journal:  Indian J Ophthalmol       Date:  2015-11       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.